Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9
Z.-H. Liu, W.-J. Liu, X.-Y. Yu, X.-L. Qi, C.-C. Sun Department of Gynecology, Binzhou Medical University Hospital, Binzhou, China
The article “Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9, by Z.-H. Liu, W.-J. Liu, X.-Y. Yu, X.-L. Qi, C.-C. Sunu, published in Eur Rev Med Pharmacol Sci 2020; 24 (20): 10375-10382–DOI: 10.26355/eurrev_202010_23387–PMID: 33155193” has been retracted by the authors due to inaccuracies related to the misuse of Table I.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/23387
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Z.-H. Liu, W.-J. Liu, X.-Y. Yu, X.-L. Qi, C.-C. Sun
Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 11
Pages: 3798-3798
DOI: 10.26355/eurrev_202206_28945